1-12 of 12
Christopher P Fox, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (liso-cel) Vs Axicabtagene Ciloleucel (axi-cel) and Tisagenlecleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

David G. Maloney, MD PhD, John Kuruvilla, MD, Christopher P Fox, MD PhD, Guillaume Cartron, MD PhD, Daniel Li, PhD, Jens Hasskarl, MD, Ashley Bonner, PhD, Yixie Zhang, PhD, Fei Fei Liu, BSc, MBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-137719
Published: 2020
Journal Articles

Ibrutinib and Obinutuzumab in CLL: MRD Responses Sustained for Several Years with Deepest MRD Depletion in Patients with >1 Year Prior Ibrutinib Exposure

Andy C. Rawstron, PhD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Shanna Maycock, BSc, MSc, Nichola Webster, Kristian Brock, PhD, Rebecca H. Boucher, BSc, MSc, PhD, Francesca Yates, PhD, Rebecca Jarvis, BSc, Surita Dalal, PhD, Ruth M. de Tute, PhD FRCPath, Paul Moss, MBBS, PhD FRCP, Donald Macdonald, MBChB, MD FRCP, PhD FCRPath, Piers Patten, MD PhD, Christopher Fegan, Andrew Pettitt, MA, MB BChir, PhD MRCP, MRCPath, Christopher P. Fox, MD PhD, Adrian Bloor, PhD FRCP, FRCPath, Oonagh Sheehy, MB BCh BAO, MRCP, FRCPath, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-136990
Published: 2020
Journal Articles

AVAIL-T: A Phase 2a Trial of Avelumab, and Anti-PD-L1 Antibody, in Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL)

Matthew J Ahearne, Charlotte Gaskell, BSc, MSc, Aimee E Jackson, BSc, MSc, Clare Morland, PhD, Louise Hopkins, Nadia Nawaz, Matthew A Timmins, Christopher P Fox, MD PhD, Graham P. Collins, MD DPhil, Andrew Davies, David John Lewis, MD, Kate Cwynarski, Kim Linton, MBChB, MRCP, PhD, Pam McKay, MD, Rod Johnson, Simon D. Wagner
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-136061
Published: 2020
Journal Articles

Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings

Lindsey E. Roeker, MD, Christopher P. Fox, MD PhD, Toby A. Eyre, John N. Allan, MD, Stephen J. Schuster, MD, Chadi Nabhan, MD, Brian T. Hill, MD PhD, Nirav N Shah, MD, Frederick Lansigan, MD, Maryam Yazdy, MD, Nicole Lamanna, MD, Bruce Cheson, MD, Arun K Singavi, MD, Catherine C. Coombs, MD, Paul Barr, MD, Alan P Skarbnik, MD, Mazyar Shadman, MD MPH, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Allison M. Winter, MD, Joanna Rhodes, MD, Colleen Dorsey, BSN, RN, Hannah Morse, BSN, John M. Pagel, MD PhD, Annalynn M Williams, MS, Ryan Jacobs, MD, Andre Goy, MD, Sivraj Muralikrishnan, MD, Laurie Pearson, MD, Andrea Sitlinger, MD, Neil Bailey, MSc, Anna Schuh, MD PhD, Danielle M. Brander, MD, Amy A Kirkwood, MSc, Anthony R Mato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4410.
https://doi.org/10.1182/blood-2018-99-118159
Published: 2018
Journal Articles

Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study

Anthony R Mato, MD, Maryam Sarraf Yazdy, MD, Brian T. Hill, MD PhD, Mazyar Shadman, Hande Tuncer, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, John N. Allan, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Chadi Nabhan, MD, Paul Barr, MD, Jennifer R. Brown, MD PhD, Christopher P. Fox, MD PhD, Joanna Rhodes, MD, Anna Schuh, MD PhD, Toby A. Eyre, MD, Nicole Lamanna, MD, Nitin Jain, MD, William G. Wierda, MD PhD, Alan P Skarbnik, MD, Lindsey E. Roeker, MD, Rajat Bannerji, MD PhD, Andrew M. Evens, MD, Frederick Lansigan, MD, Jennifer C. Samp, MS, PharmD, Jacqueline Nielsen, PhD, James M. Pauff, Thomas J. Kipps, MD PhD, Stephen J. Schuster, MD, George A Follows, MD PhD, Bruce Cheson, MD, Barbara Eichhorst
Journal: Blood
Blood (2018) 132 (Supplement 1): 4759.
https://doi.org/10.1182/blood-2018-99-119015
Published: 2018
Journal Articles

Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival

Nicolas Martinez-Calle, MD #, Edward Poynton, Alia Alchawaf, MD, Shireen Kassam, MD, Matthew Horan, MD, Mark Rafferty, MBBS, BSc, Phillipa Kelsey, MD, Gemma Scott, MD, Stephanie Bruce, MD, Hannah Buckley, MD, Sophie Jones, MD, Yeong Jer Lim, MD, Ngu Loretta, MD, David Lewis, MD, Thankamma Ajithkumar, MD, Dominic J. Culligan, Clare Rowntree, MD, Josh Wright, MD, Pamela McKay, MD, Samih Fourali, MD, Toby A. Eyre, Jeffrey Smith, MD, Wendy Osborne, MD, Deborah Yallop, MBBS FRCP FRCPath PhD, Kim Linton, MBChB PhD, Christopher P. Fox, MD PhD, Kate Cwynarski, MD PhD # (#Shared authorship)
Journal: Blood
Blood (2018) 132 (Supplement 1): 572.
https://doi.org/10.1182/blood-2018-99-111901
Published: 2018
Journal Articles

Efficacy of Systemic Therapies for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL): A Systematic Literature Review (SLR)

Emmanuel Bachy, MD PhD, Christopher P. Fox, MD PhD, Luca Arcaini, MD, Francisco J. Hernandez-Ilizaliturri, MD, Susannah Howlett, Sonya J. Snedecor, Jacob Franek, Omer Zaidi, Ashley Tabah
Journal: Blood
Blood (2018) 132 (Supplement 1): 2266.
https://doi.org/10.1182/blood-2018-99-112892
Published: 2018
Journal Articles

Ibrutinib and Obinutuzumab in CLL: Improved MRD Response Rates with Substantially Enhanced MRD Depletion for Patients with >1 Year Prior Ibrutinib Exposure

Andy Rawstron, PhD, Talha Munir, Kristian Brock, MSc, BSc, Nichola Webster, Samuel Munoz Vicente, MSc, Francesca Yates, PhD, Sophie Cramp, MSc, BSc, Rebecca Bishop, BSc, Surita Dalal, PhD, Ruth M De Tute, BSc,MSc, Oonagh Sheehy, Andrew Pettitt, FRCPath, PhD, Christopher P. Fox, MD PhD, Stephen Devereux, PhD, Christopher Fegan, MD, Donald MacDonald, Adrian Bloor, MA MB BChir PhDFCRP FRCPath, Peter Hillmen, MB ChB, PhD FRCP, FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 181.
https://doi.org/10.1182/blood-2018-181
Published: 2018
Journal Articles

CNS Relapse Risk in Consecutive R-CHOP/R-Mini-CHOP-Treated Elderly DLBCL Is Low, with High Risk Particularly Apparent in Those with CNS IPI 5-6 and/or Renal/Adrenal Involvement

Toby A. Eyre, Nicolas Martinez-Calle, MD #, Amy A Kirkwood, MSc, Catherine Hildyard, Murali Kesavan, Joseph Butler, Carolyn Mercer, Faouzi Djebbari, Hannah Plaschkes, John Griffith, Stephen Booth, Andrew McMillan, Mark Bishton, Christopher P. Fox, MD PhD, Graham P. Collins, MB BS DPhil, Chris Hatton
Journal: Blood
Blood (2018) 132 (Supplement 1): 1694.
https://doi.org/10.1182/blood-2018-99-111010
Published: 2018
Journal Articles

Ibrutinib Plus Venetoclax in Relapsed/Refractory CLL: Results of the Bloodwise TAP Clarity Study

Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Andy Rawstron, BSc, PhD, Kristian Brock, MSc, BSc, Samuel Munoz Vicente, MSc, Francesca Yates, PhD, Rebecca Bishop, BSc, Donald Macdonald, Christopher Fegan, MD, Alison McCaig, PhD, Anna Schuh, MD PhD, Andrew Pettitt, FRCPath, PhD, John G. Gribben, Piers E.M. Patten, BSc, MRCP, MRCPath, PhD, Stephen Devereux, PhD, Adrian Bloor, MA MB BChir PhDFCRP FRCPath, Christopher P. Fox, MD PhD, Francesco Forconi, MD DM, PhD FRCPath, Talha Munir
Journal: Blood
Blood (2018) 132 (Supplement 1): 182.
https://doi.org/10.1182/blood-2018-182
Published: 2018
Journal Articles

Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients

Anthony R. Mato, MD MSCE, Lindsey E. Roeker, MD, Toby A. Eyre, Chadi Nabhan, MD, Nicole Lamanna, MD, Brian T. Hill, MD PhD, Danielle M. Brander, MD, Paul Barr, MD, Frederick Lansigan, MD, Bruce Cheson, MD, Arun K Singavi, MD, Maryam Yazdy, MD, Nirav N Shah, MD, John N. Allan, MD, Erica B Bhavsar, BS, Joanna Rhodes, MD, Kaitlin Kennard, RN, BSN, Stephen J. Schuster, MD, Annalynn M Williams, MS, Alan P Skarbnik, MD, Andre Goy, MD, Catherine C. Coombs, MD, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Ryan Jacobs, MD, Allison M. Winter, MD, John M. Pagel, MD PhD, Neil Bailey, MSc, Anna Schuh, MD PhD, Mazyar Shadman, MD MPH, Andrea Sitlinger, MD, Hanna Weissbrot, BS, Sivraj Muralikrishnan, MD, Amy A Kirkwood, MSc, Christopher P. Fox, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3142.
https://doi.org/10.1182/blood-2018-99-114840
Published: 2018
Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplantation for Extra-Nodal NK/T Lymphoma in Western Patients; A Study From the European Group for Blood and Marrow Transplantation (EBMT).

Christopher P Fox, MD, PhD, Ariane Boumendil, Herve Finel, Jian Jian Luan, Gulsan Sucak, MD, Didier Blaise, MD, Jurgen Finke, MD, Karl-Heinz Pflüger, MD, Hendrik Veelken, MD PhD, Norbert C Gorin, MD, Xavier Poiré, MD, Arnold Ganser, Norbert Schmitz, MD, Peter Dreger, MD, Anna Sureda, MD
Journal: Blood
Blood (2012) 120 (21): 3148.
https://doi.org/10.1182/blood.V120.21.3148.3148
Published: 2012